The Role of Global Physical Capacity Score in Key Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Journal of Clinical Medicine · 29.05.2025 · 14 (11) · 3821
DOI: 10.3390/jcm14113821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.05.2025. Verfasst von Nicola Verrelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Movement and Wellness, National Institute of Gastroenterology IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to metabolic syndrome, type 2 diabetes, and obesity. This study investigates the relationship between physical capacity, assessed by the Global Physical Capacity Score (GPCS), and MASLD-related parameters, including hepatic steatosis (CAP score), insulin resistance (HOMA-IR), and body mass index (BMI).
Methods
A cross-sectional analysis was performed on 204 individuals with MASLD (mean age: 50 years; 57.6% males). Participants underwent physical tests to determine their GPCS. Hepatic steatosis was assessed using FibroScan® (Echosens, Paris, France), and metabolic markers were collected from fasting blood samples. Statistical analyses included linear and logistic regression models adjusted for potential confounders.
Results
A higher GPCS was inversely associated with CAP (β = −5.30; p < 0.05), HOMA-IR (β = −0.28; p < 0.001), and BMI (β = −0.96; p < 0.001). Logistic regression analysis confirmed a lower risk of severe hepatic steatosis (OR = 0.44; p < 0.05), obesity (OR = 0.39; p < 0.05), and insulin resistance (OR = 0.32; p < 0.001) in individuals with higher GPCS values.
Conclusions
The GPCS may indicate MASLD severity and reflect metabolic and hepatic health. Our findings support the promotion of physical activity and suggest a potential role for GPCS in risk stratification and personalized interventions for patients with MASLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Movement and Wellness, National Institute of Gastroenterology IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
- Data Science, National Institute of Gastroenterology IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
- Core Facility Biobank, National Institute of Gastroenterology IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
- Gastroenterology Unit, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
ORCID-Profile: Caterina Bonfiglio, Isabella Franco, Endrit Shahini, Antonella Bianco
Förderung
- Italian Ministry of Health
Zitieren
APA
Verrelli, N., Bonfiglio, C., Franco, I., Bagnato, C. B., Stabile, D., Shahini, E., & Bianco, A. (2025). The Role of Global Physical Capacity Score in Key Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Clinical Medicine, 14(11), 3821. https://doi.org/10.3390/jcm14113821
Vancouver
Verrelli N, Bonfiglio C, Franco I, Bagnato CB, Stabile D, Shahini E, et al. The Role of Global Physical Capacity Score in Key Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Clinical Medicine. 2025;14(11):3821. doi:10.3390/jcm14113821
BibTeX
@article{Verrelli2025,
author = {Verrelli, Nicola and Bonfiglio, Caterina and Franco, Isabella and Bagnato, Claudia Beatrice and Stabile, Dolores and Shahini, Endrit and Bianco, Antonella},
title = {The Role of Global Physical Capacity Score in Key Parameters of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {11},
pages = {3821},
doi = {10.3390/jcm14113821}
}
EUVIMED